文献速递物质与行为成瘾

聚焦超声神经调控治疗物质使用障碍

Focused Ultrasound Neuromodulation for Substance Use Disorder.
PubMed 文献 · Biol Psychiatry · 2026-05-28

物质使用障碍(SUD)患病率高、过量死亡风险大且获批药物疗法有限,亟需新疗法。聚焦超声(FUS)作为一种无创、可精准靶向皮层下奖赏环路结构的神经调控手段,临床前与临床证据支持其治疗SUD的潜力;临床显示FUS可减少渴求与使用并改善情绪行为症状,但现有临床证据多为开放标签设计且治疗例数极少,需更大样本假对照试验验证。

要点

  • FUS无创且可精准靶向奖赏环路皮层下结构,是SUD的潜在辅助治疗。
  • 临床前证据显示FUS调控奖赏神经环路可减少药物相关奖赏与行为,并提示存在性别差异。
  • 临床证据提示FUS可减少渴求与使用、改善情绪行为症状,但证据来自开放标签且例数极少。

核心结论

  • 聚焦超声神经调控对物质使用障碍具有治疗潜力,但现有临床证据不足以得出结论,需假对照试验验证。

研究设计与样本

  • 本文为综述,汇总聚焦超声神经调控治疗物质使用障碍的临床前与临床研究证据。

主要发现

  • 临床前研究显示,FUS神经调控与开放血脑屏障两种方式均可通过调控奖赏神经环路关键成分减少药物相关奖赏与行为。
  • 关键临床前证据提示上述调控机制存在性别差异。
  • 临床研究提示FUS可减少多种物质的渴求与使用并改善情绪/行为症状,但证据来自开放标签设计且治疗例数极少。

临床怎么用

  • FUS可作为物质使用障碍的潜在辅助治疗手段,但当前应仅限研究场景使用并谨慎解读开放标签结果。
  • 后续需开展更大样本的假对照试验,并拓展至更多物质种类与脑靶点、系统优化FUS参数。

局限性

  • 现有临床证据多为开放标签设计,且接受治疗例数极少,结论需谨慎解读。
  • 尚缺乏更大样本的假对照试验验证疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Given the prevalence of substance use disorder (SUD), elevated overdose death rates, and limited approved pharmacotherapies for SUD, new treatment approaches are necessary. Neuromodulation is a potential adjunctive treatment for SUD to reduce substance use and risk factors associated with drug use recurrence, such as craving. One form of neuromodulation, focused ultrasound (FUS), has significant potential given that it is noninvasive and capable of precisely targeting subcortical structures implicated in the brain's reward circuity. Both preclinical and clinical findings support FUS as a treatment for SUD, and several ongoing or planned studies are investigating its utility further. Preclinical studies using both FUS neuromodulation and blood-brain barrier opening approaches have demonstrated that FUS reduces drug-associated reward and behaviors by modulating critical components of the reward neurocircuitry. Key preclinical evidence suggests sex differences in these modulation mechanisms. Clinical findings suggest that FUS can reduce craving and use for several substances and improve emotional/behavioral symptoms, but these findings should be interpreted with caution given the open-label design and very limited number of treated cases. Given this, sham-controlled trials in larger cohorts are necessary before any conclusions can be drawn. Expanding research to incorporate a broader range of substances and brain targets while systematically refining FUS parameters is essential to fully realize the therapeutic potential of FUS as a treatment for SUD.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Mahoney Iii JJ, Thompson-Lake DGY, Johnson L, et al. Focused Ultrasound Neuromodulation for Substance Use Disorder. Biol Psychiatry. 2026. PMID: 42214740. doi:10.1016/j.biopsych.2026.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。